VC-backed Miroculus buys diagnostics specialist Kapplex
Kapplex, a Canadian developer of instruments and consumables for diagnostic markets, has been acquired by U.S.-based biotechnology company Miroculus. No financial terms were released. Kapplex was spun-off from the University of Toronto in 2012 in partnership with MaRS Innovation. Its combination with Miroculus will create a single platform that supports clinicians in detecting complex conditions, such as cancer, in a minimally invasive way, the companies said. San Francisco's Miroculus has raised funding from angel investors and venture capital firms, including Nazca Ventures.
3 May 2016•4 mins read
